SLU-PP-332 Explained: The "Exercise in a Pill" Research Compound

SLU-PP-332 is one of the fastest-rising names in metabolic research. The idea behind it is simple and bold: a compound that switches on the same genes muscle switches on during endurance exercise, without the exercise. In mice, it did. It is often grouped with research peptides because it is studied alongside GLP-1 compounds, but SLU-PP-332 is not a peptide. It is a small molecule that switches on the estrogen-related receptors (ERRs), and that difference matters for how you handle it.

This guide covers what SLU-PP-332 is, how it works, what the published studies show, and what to check when you buy it. All of it is for laboratory and research use only. Nothing here is a dosing plan, medical advice or a suggestion for human use.

Key Takeaways

• SLU-PP-332 is a lab-made small molecule that switches on all three estrogen-related receptors, most strongly ERRalpha. It was first made at Saint Louis University and is studied as an "exercise mimetic".
• It is not a peptide. It is sold as a research compound and shares lab space with metabolic peptides like retatrutide and tirzepatide.
• Switching on the ERRs turns up the genes for new mitochondria, energy production and fat burning.
• In mice, it raised endurance and cut fat gain while keeping lean mass.
• There is no published human data on how it behaves in the body or how safe it is. Every finding so far is from animals.
• Lyze Labs supplies SLU-PP-332 at 99%+ purity, third-party HPLC tested with a published COA, with free discreet worldwide shipping in 7 to 14 days.

What Is SLU-PP-332?

SLU-PP-332 switches on the estrogen-related receptors, a family of three receptors inside the cell nucleus: ERRalpha, ERRbeta and ERRgamma. Researchers at Saint Louis University built it as a chemical probe for ERR signaling (Billon, 2023). It drew attention fast as a possible "exercise mimetic", a compound that copies some of the gene activity of exercise.

The word "peptide" causes confusion. SLU-PP-332 is a small organic molecule, not a chain of amino acids. It dissolves poorly in water, so the choice of solvent matters a lot in the lab. Treat it as a small-molecule research chemical, not as a typical peptide.

For broader context on how peptide and small-molecule metabolic compounds are categorized and verified, the research peptide glossary is a useful companion reference.

How the ERR Agonist Mechanism Works

Estrogen-related receptors are master switches for how cells make energy. Despite the name, they do not bind estrogen. They control the genes that run the mitochondria, the cell's power plants. When SLU-PP-332 binds them, especially ERRalpha, it sets off a chain of signals that, in research models, looks a lot like the body's response to aerobic exercise.

One well-studied step is a rise in DDIT4, a protein that jumps after a short bout of aerobic exercise. By switching on ERRalpha, SLU-PP-332 starts the same "acute aerobic exercise" gene program. In treated mouse muscle, the gene patterns matched those of exercise, with more of the machinery for energy production and fat burning, and more of the endurance-type (type IIa) muscle fibers.

In plain terms, the compound pushes cells to burn fat for fuel and build more mitochondria: the same changes endurance training produces over time. That is why it is called an exercise mimetic, not a stimulant or an appetite suppressant.

What the Research Shows: Key Preclinical Findings

The mouse studies are what started the buzz. Read carefully, and in context, they are striking (Billon, 2023; Billon, 2024).

A few points matter. First, every one of these results comes from animals. No Phase 1 human trial has been published, and nothing is known about how it behaves in people. Second, the fast switch to fat burning is one of the most interesting signals: it suggests the compound puts the body in a fasting-like or exercise-like state quickly. That is a different mechanism from the gut-hormone drugs, which makes side-by-side studies especially useful.

The work is spreading beyond muscle. Related ERR agonists improved heart function in mouse models of heart failure (Xu, 2024). And in 2026, anti-doping scientists mapped how the body breaks SLU-PP-332 down so sports testing labs can detect it (Möller, 2026).

SLU-PP-332 vs. GLP-1 Research Compounds

Researchers often want to place SLU-PP-332 next to the GLP-1, dual and triple agonists that lead metabolic research. The mechanisms are different, which is exactly why they are studied together rather than as substitutes.

For study design, the point is that they complement each other. Gut-hormone compounds work on the "energy in" side, SLU-PP-332 on the "energy out" side. To frame the contrast, see the retatrutide kit, the tirzepatide kit and the retatrutide vs tirzepatide vs semaglutide comparison.

Handling, Reconstitution, and Stability Considerations

SLU-PP-332 is an oily small molecule that dissolves poorly in water, so it does not behave like a typical water-soluble peptide. In published lab work it needed suitable solvents to reach workable strengths, and bacteriostatic water alone is generally a poor fit. Researchers should consult the certificate of analysis and material data for solvent compatibility before preparing any working solution.

The usual good practice still applies: store the material cold and away from light, avoid freezing and thawing stock solutions again and again, and label every preparation with its strength and date. The peptide storage and stability guide and the reconstitution walkthrough cover the general principles, but for a small molecule like this, the compound's own solubility data comes first.

Purity, Verification, and Why It Matters

With a breakout compound, demand outpaces quality control across the supplier landscape. A mislabeled or underpurity sample will quietly corrupt every downstream result. This is why batch verification is not optional.

Every batch of SLU-PP-332 from Lyze Labs is third-party HPLC tested and ships with a published certificate of analysis confirming 99%+ purity. Researchers can verify the batch identity against the COA before committing material to a study. If you are new to reading these documents, the guide to verifying research peptide purity and COA explains exactly what to look for, and the research peptide scam red flags breakdown shows the warning signs of suppliers who cut corners.

How to Order SLU-PP-332 From Lyze Labs

Lyze Labs is trusted by researchers in 150+ countries, with 10,000+ orders shipped, and supplies SLU-PP-332 with the verification a serious laboratory needs.

• Purity: 99%+, third-party HPLC tested, published COA per batch.
• Kit: ten vials of 5 mg from one batch.
• Shipping: free and tracked worldwide, most orders in 7 to 14 days, delivery guaranteed.
• Payment: Visa, Mastercard, Amex, PayPal, Apple Pay, Google Pay, bank transfer, local wallets and bank apps in your region, or crypto (USDT, USDC, BTC).

Review the current verified batch on the SLU-PP-332 product page. Orders paid before the daily batch closes are processed that day.

Frequently Asked Questions

What is SLU-PP-332 and is it a peptide?

SLU-PP-332 is a lab-made small molecule that switches on the estrogen-related receptors (ERRalpha, ERRbeta and ERRgamma), studied as an exercise mimetic. It is not a peptide, meaning it is not a chain of amino acids, but it is researched alongside metabolic peptides like retatrutide. It is for laboratory and research use only.

How does the SLU-PP-332 peptide mechanism work?

SLU-PP-332 switches on the estrogen-related receptors, most strongly ERRalpha, which turn up the genes for new mitochondria, energy production and fat burning. In research models this copies the gene activity of a bout of aerobic exercise, including a rise in DDIT4, which is why it is called an exercise mimetic.

What did SLU-PP-332 research findings show?

In mouse studies, SLU-PP-332 raised endurance (mice ran about 70% longer), cut body weight by about 12% over 28 days in obese mice, cut fat gain by over 90% and kept lean mass. It also switched the body toward burning fat within about two hours. All findings are from animals; there is no published human data.

Is SLU-PP-332 safe for humans?

There is no published human safety data, and no Phase 1 trial has been completed. It must be treated as a research compound for laboratory use only. It is not approved for human use.

How is SLU-PP-332 different from retatrutide or tirzepatide?

SLU-PP-332 is a small molecule that raises energy use and the cell's capacity to burn fuel. Retatrutide and tirzepatide are peptide gut-hormone copies that mainly lower appetite and food intake. They work on opposite sides of energy balance, which is why researchers study them as partners rather than substitutes.

Where can I buy SLU-PP-332 with a verified COA?

Lyze Labs supplies SLU-PP-332 at 99%+ purity, third-party HPLC tested with a published certificate of analysis for every batch. Shipping is free and tracked to 150+ countries, and most orders arrive in 7 to 14 days.

Studies Cited

• Billon C, et al. (2023). Synthetic ERRα/β/γ agonist induces an ERRα-dependent acute aerobic exercise response and enhances exercise capacity. ACS Chemical Biology.
• Billon C, et al. (2024). A synthetic ERR agonist alleviates metabolic syndrome. Journal of Pharmacology and Experimental Therapeutics.
• Xu W, et al. (2024). Novel pan-ERR agonists ameliorate heart failure through enhancing cardiac fatty acid metabolism and mitochondrial function. Circulation.
• Möller T, et al. (2026). In vitro metabolism and analytical characterization of SLU-PP-332 and SLU-PP-915: novel pan-ERR agonists with doping potential. Rapid Communications in Mass Spectrometry.